Skip to main content

Table 2 Assessment schedule

From: Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial

 

Pre treatment

Chemoradiotherapy(CRT)

The end of CRT

Post treatment

1w

2w

3w

4w

5w

6w

7w

1w

2w

3w

4w

Performance status

v

v

  

v

  

v

    

v

Photograph

v

v

v

v

v

v

v

v

 

v

v

v

v

PRO

v

v

v

v

v

v

v

v

 

v

v

v

v

Body weight

v

    

v

 

v

    

v

Blood exam

v

            

Adverse events

v

v

v

v

v

v

v

v

 

v

v

v

v

  1. Abbreviation: PRO patient reported outcome, CDDP cisplatin, RT radiotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us